Use of Ziprasidone in Parkinsonian Patients With Psychosis

Wolters, 2001, Management of psychosis in Parkinsons disease., Curr Opin Neurol, 14, 499, 10.1097/00019052-200108000-00011

Goetz, 2000, Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients., Neurology, 55, 789, 10.1212/WNL.55.6.789

Factor, 2001, Clozapine for the treatment of drug-induced psychosis in Parkinsons disease: results of the 12 week open label extension in the PSYCLOPS trial., Mov Disord, 16, 135, 10.1002/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q

Durif, 1997, Low-dose clozapine improves dyskinesias in Parkinsons disease., Neurology, 48, 658, 10.1212/WNL.48.3.658

Durif, 2004, Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study., Neurology, 62, 381, 10.1212/01.WNL.0000110317.52453.6C

Fernandez, 2003, Treatment of psychosis in Parkinsons disease: safety considerations., Drug Saf, 26, 643, 10.2165/00002018-200326090-00004

Juncos, 2004, Quetiapine improves psychotic symptoms and cognition in Parkinsons disease., Mov Disord, 19, 29, 10.1002/mds.10620

Reddy, 2002, The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia., Mov Disord, 17, 676, 10.1002/mds.10176

Schooler, 2003, Maintaining symptom control: review of ziprasidone long-term efficacy data., J Clin Psychiatry, 64, 26

Caley, 2002, Ziprasidone: the fifth atypical antipsychotic., Ann Pharmacother, 36, 839, 10.1345/aph.1A053

Glassman, 2001, Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death., Am J Psychiatry, 158, 1774, 10.1176/appi.ajp.158.11.1774

Stahl, 2003, The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice., J Clin Psychiatry, 64, 6

Goodnick, 2001, Ziprasidone: profile on safety., Exp Opin Pharmacother, 2, 1655, 10.1517/14656566.2.10.1655

Carnahan, 2001, Ziprasidone, a new atypical antipsychotic drug., Pharmacotherapy, 21, 717, 10.1592/phco.21.7.717.34575

Cummings, 1994, The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia., Neurology, 44, 2308, 10.1212/WNL.44.12.2308

Martinez-Martin, 1994, Unified Parkinsons Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group., Mov Disord, 9, 76, 10.1002/mds.870090112

van Hilten, 1994, Rating impairment and disability in Parkinsons disease: evaluation of the Unified Parkinsons Disease Rating Scale., Mov Disord, 9, 84, 10.1002/mds.870090113

1988, Psychopharmacol Bull., , 24, 781

Morgante, 2002, Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinsons disease., Neurol Sci, 23, S89, 10.1007/s100720200084

Menza, 1999, Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinsons disease., Ann Clin Psychiatry, 11, 141, 10.3109/10401239909147063

Connemann, 2004, Ziprasidone in Parkinsons disease psychosis., Can J Psychiatry, 49, 73, 10.1177/070674370404900119

Gray, 2004, Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinsons disease: a diagnostic challenge., Hum Psychopharmacol, 19, 205, 10.1002/hup.578

Bennett, 1994, Suppression of dyskinesias in advanced Parkinsons disease: moderate daily clozapine doses provide long-term dyskinesia reduction., Mov Disord, 9, 409, 10.1002/mds.870090406

Katzenschlager, 2004, Low dose quetiapine for drug induced dyskinesias in Parkinsons disease: a double blind cross over study., J Neurol Neurosurg Psychiatry, 75, 295

Correll, 2004, Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies., Am J Psychiatry, 161, 414, 10.1176/appi.ajp.161.3.414

Keck, 2004, Ziprasidone-related tardive dyskinesia., Am J Psychiatry, 161, 175, 10.1176/appi.ajp.161.1.175-a

Senard, 2001, Orthostatic hypotension in patients with Parkinsons disease: pathophysiology and management., Drugs Aging, 18, 495, 10.2165/00002512-200118070-00003

Fernandez, 1999, Quetiapine for the treatment of drug-induced psychosis in Parkinsons disease., Mov Disord, 14, 484, 10.1002/1531-8257(199905)14:3<484::AID-MDS1016>3.0.CO;2-B

Sartori, 1984, Torsade de pointe. Malignant cardiac arrhythmia induced by amantadine poisoning., Am J Med, 77, 388, 10.1016/0002-9343(84)90728-9

Kato, 2001, Antipsychotic medication: effects on regulation of glucose and lipids., Exp Opin Pharmacother, 2, 1571, 10.1517/14656566.2.10.1571

Nasrallah, 2003, A review of the effect of atypical antipsychotics on weight., Psychoneuroendocrinology, 28, 83, 10.1016/S0306-4530(02)00114-2